摘要
中医药注射剂治疗心血管疾病具有独特优势,参麦注射液、生脉注射液、丹参注射液、川芎嗪注射液、红花注射液等广泛应用于心力衰竭、冠心病、心绞痛、高血压、病毒性心肌炎等心血管疾病的治疗,疗效良好,副作用小。中药制剂成分繁杂,成分间的生理活性作用大多不清楚,质量标准很难提高,限制中药与国际标准接轨。未来期待中药注射剂定向定量给药,安全性、稳定性、作用机制和不良反应是研究重点。
Traditional Chinese medicine injection in the treatment of cardiovascular disease has a unique advantage, Shenmai injection, Shengmai injection, Danshen injection, ligustrazine injection, safflower injection is widely used in heart failure, coronary heart disease, angina, hypertension, viral myocarditis in the treatment of cardiovascular diseases, good curative effect, little side effect. Traditional Chinese medicine composition is complicated, the physiological activity between components are not clear, it is difficult to improve the quality standard of traditional Chinese medicine in line with international standards, limit. Future administration of traditional Chinese medicine injectionsdirectional quantitative, security, stability, mechanism of action and adverse reaction is the research focus.
出处
《实用中医内科杂志》
2014年第7期180-181,共2页
Journal of Practical Traditional Chinese Internal Medicine
关键词
心力衰竭
冠心病
心绞痛
高血压
病毒性心肌炎
中药注射剂
中医药治疗
综述
Heart failure
Coronary heart disease
Angina pectoris
Hypertension
Viral myocarditis
Traditional Chinese medicine injection
Traditional Chinese Medicine treatment
Overview